Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1995 Mar;71(3):625–628. doi: 10.1038/bjc.1995.122

Whole bladder wall photodynamic therapy for refractory carcinoma in situ of the bladder.

T Uchibayashi 1, K Koshida 1, K Kunimi 1, H Hisazumi 1
PMCID: PMC2033645  PMID: 7880749

Abstract

Whole bladder wall photodynamic therapy (PDT) with haematoporphyrin derivative and an argon dye laser as a light source was performed on 34 patients with refractory carcinoma in situ (CIS) of the bladder. Twenty-five of the 34 patients (73.5%) had achieved a complete response (CR) at 3 months after the treatment. The median follow-up for these CR patients is 49.3 months. Although recurrence within 2 years of follow-up occurred in 14 (77.8%) of the 18 CR patients followed to that point, since most of the recurrent tumours were superficial and low-grade papillary tumours, transurethral resection of the bladder tumours appeared to be sufficient. Of the total of 34 patients, ten were alive with bladder intact with a mean follow-up period of 64.0 months. Skin photosensitivity and transient decrease in bladder capacity were noted as adverse reactions, caused by retention of haematoporphyrin derivative in the skin and normal portion of the bladder. These data suggest that PDT can be an effective form of therapy for CIS of the bladder.

Full text

PDF
625

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berns M. W., Dahlman A., Johnson F. M., Burns R., Sperling D., Guiltinan M., Siemens A., Walter R., Wright W., Hammer-Wilson M. In vitro cellular effects of hematoporphyrin derivative. Cancer Res. 1982 Jun;42(6):2325–2329. [PubMed] [Google Scholar]
  2. Catalona W. J., Hudson M. A., Gillen D. P., Andriole G. L., Ratliff T. L. Risks and benefits of repeated courses of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer. J Urol. 1987 Feb;137(2):220–224. doi: 10.1016/s0022-5347(17)43959-0. [DOI] [PubMed] [Google Scholar]
  3. D'Hallewin M. A., Baert L., Marijnissen J. P., Star W. M. Whole bladder wall photodynamic therapy with in situ light dosimetry for carcinoma in situ of the bladder. J Urol. 1992 Oct;148(4):1152–1155. doi: 10.1016/s0022-5347(17)36846-5. [DOI] [PubMed] [Google Scholar]
  4. Dougherty T. J., Lawrence G., Kaufman J. H., Boyle D., Weishaupt K. R., Goldfarb A. Photoradiation in the treatment of recurrent breast carcinoma. J Natl Cancer Inst. 1979 Feb;62(2):231–237. [PubMed] [Google Scholar]
  5. Henderson B. W., Waldow S. M., Mang T. S., Potter W. R., Malone P. B., Dougherty T. J. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res. 1985 Feb;45(2):572–576. [PubMed] [Google Scholar]
  6. Herr H. W., Pinsky C. M., Whitmore W. F., Jr, Sogani P. C., Oettgen H. F., Melamed M. R. Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder. J Urol. 1986 Feb;135(2):265–267. doi: 10.1016/s0022-5347(17)45604-7. [DOI] [PubMed] [Google Scholar]
  7. Hisazumi H., Miyoshi N., Naito K., Misaki T. Whole bladder wall photoradiation therapy for carcinoma in situ of the bladder: a preliminary report. J Urol. 1984 May;131(5):884–887. doi: 10.1016/s0022-5347(17)50694-1. [DOI] [PubMed] [Google Scholar]
  8. Kavoussi L. R., Torrence R. J., Gillen D. P., Hudson M. A., Haaff E. O., Dresner S. M., Ratliff T. L., Catalona W. J. Results of 6 weekly intravesical bacillus Calmette-Guerin instillations on the treatment of superficial bladder tumors. J Urol. 1988 May;139(5):935–940. doi: 10.1016/s0022-5347(17)42722-4. [DOI] [PubMed] [Google Scholar]
  9. Koshida K., Hisazumi H., Komatsu K., Hirata A., Uchibayashi T. Possible advantages of aluminum-chloro-tetrasulfonated phthalocyanine over hematoporphyrin derivative as a photosensitizer in photodynamic therapy. Urol Res. 1993;21(4):283–288. doi: 10.1007/BF00307712. [DOI] [PubMed] [Google Scholar]
  10. Lamm D. L., Stogdill V. D., Stogdill B. J., Crispen R. G. Complications of bacillus Calmette-Guerin immunotherapy in 1,278 patients with bladder cancer. J Urol. 1986 Feb;135(2):272–274. doi: 10.1016/s0022-5347(17)45606-0. [DOI] [PubMed] [Google Scholar]
  11. Naito K., Hisazumi H., Uchibayashi T., Amano T., Hirata A., Komatsu K., Ishida T., Miyoshi N. Integral laser photodynamic treatment of refractory multifocal bladder tumors. J Urol. 1991 Dec;146(6):1541–1545. doi: 10.1016/s0022-5347(17)38160-0. [DOI] [PubMed] [Google Scholar]
  12. Prout G. R., Jr, Griffin P. P., Daly J. J., Heney N. M. Carcinoma in situ of the urinary bladder with and without associated vesical neoplasms. Cancer. 1983 Aug 1;52(3):524–532. doi: 10.1002/1097-0142(19830801)52:3<524::aid-cncr2820520324>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  13. Prout G. R., Jr, Griffin P. P., Daly J. J. The outcome of conservative treatment of carcinoma in situ of the bladder. J Urol. 1987 Oct;138(4):766–770. doi: 10.1016/s0022-5347(17)43366-0. [DOI] [PubMed] [Google Scholar]
  14. Utz D. C., Hanash K. A., Farrow G. M. The plight of the patient with carcinoma in situ of the bladder. J Urol. 1970 Feb;103(2):160–164. doi: 10.1016/s0022-5347(17)61913-x. [DOI] [PubMed] [Google Scholar]
  15. Weishaupt K. R., Gomer C. J., Dougherty T. J. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res. 1976 Jul;36(7 Pt 1):2326–2329. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES